Stephen Taub For Members Only Biopharma Funds’ Rally Rides on Narrow Leadership Big moves in a handful of biotech stocks powered April gains, but most funds continue to lag indexes in 2026. Stephen Taub May 13, 2026 Andrey Rudakov/Bloomberg